HPV Testing and PAP Test Market Projected to Reach USD 9 Billion by 2032

1
HPV Testing and PAP Test Market Projected to
Reach USD 9 Billion by 2032
2

• Industry Insights

• Global HPV Testing and PAP Test Market size will
  expand significantly through 2032. Recent
  advancements in HPV and PAP tests will create
  notable growth opportunities for the industry.
  Advances in image analysis and AI have led to the
  development of computer-assisted systems for Pap
  test interpretation. These systems can aid
  pathologists by highlighting abnormal cells,
  potentially improving the accuracy and efficiency
  of the screening process.
• The overall global HPV testing and PAP test
  market is divided based on test, technology,
  end-use, and region.
• Based on the test, industry share from the
  co-testing segment will grow at over 16 CAGR
  from 2023 to 2032. The rising prevalence of
  cervical cancer and HPV-related sexually
  transmitted diseases has increased the demand for
  co-testing. As per the American Cancer Society,
  in 2023, around 13,960 new invasive cervical
  cancer cases will be diagnosed in the U.S. alone.
  Co-testing provides higher sensitivity in
  detecting cervical abnormalities compared to
  either test alone. The combination of HPV testing
  and Pap testing improves the detection of
  high-grade precancerous lesions and early-stage
  cervical cancer.

3

• Based on the technology, industry value from the
  polymerase chain reaction (PCR) segment will
  register lucrative gains through 2032. High
  sensitivity and specificity of PCR tests allow
  for the accurate detection and identification of
  HPV DNA, favoring segment growth. Moreover, PCR
  testing can identify the presence of persistent
  HPV infections, which are considered to have a
  higher risk of developing cervical cancer.
  Growing awareness about the early detection of
  HPV infection will further contribute to segment
  growth.
• Based on the end use, industry value from the
  diagnostic centers segment will witness
  substantial gains through 2032. Growing
  preference towards diagnostic laboratories owing
  to the availability of advanced technologies and
  cost-effective treatment in these facilities is
  leading to segment growth. These centers also
  offer accurate and early disease diagnosis, which
  increases patient footfall. Surging number of
  diagnostic centers will further create lucrative
  opportunities for segment growth.

4

• Regional Analysis

From the regional perspective, the Asia Pacific
HPV testing and PAP test market size will reach
over USD 2.5 billion by 2032. Surging female
population base's susceptibility to cervical
cancer has increased the need for HPV and PAP
testing in the region. Moreover, regional
expansion can also be attributed to expanding
healthcare infrastructure, in line with favorable
regulatory scenarios for modalities. As per IBEF,
India's medical device market will reach USD 50
billion by 2025.

• Competitive Analysis

• Hologic
• Quest Diagnostics
• Abbott Laboratories
• Becton Dickinson Company
• Onco Health Corporation
• Arbor Vita Corporation
• Femasys
• Qiagen N.V.
• Seegene
• Mylab Discovery Solutions Pvt. Ltd.

5
Biotechnology Instruments Market _at_
https//www.gminsights.com/industry-analysis/next-
generation-sequencing-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/3
247
Request for customization _at_ https//www.gminsights
.com/roc/3247
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com